Keyphrases
Heterozygote
100%
Homozygous Familial Hypercholesterolemia (HoFH)
100%
Atherosclerotic Change
37%
Adulthood
25%
Early Intervention
25%
Cholesterol Levels
25%
Young Age
25%
Early Detection
25%
Cardiovascular Events
25%
Metabolism
12%
Therapeutic Target
12%
Major Change
12%
Early Diagnosis
12%
Pediatric Patients
12%
Cardiovascular Disease
12%
New Drugs
12%
First-line Therapy
12%
Genetic Disease
12%
Preventive Measures
12%
Low-density Lipoprotein Cholesterol Level
12%
Statins
12%
Low-density Lipoprotein
12%
Pharmacological Agents
12%
Atherosclerotic Cardiovascular Disease (ASCVD)
12%
Ezetimibe
12%
Lipoprotein Apheresis
12%
Lipid Management
12%
Customized Treatment
12%
Paediatric Familial Hypercholesterolaemia
12%
Medicine and Dentistry
Adolescent
100%
Heterozygote
100%
Familial Hypercholesterolemia
100%
Cardiovascular System
25%
Prematurity
12%
Childbirth
12%
Pediatrics Patient
12%
Cardiovascular Disease
12%
Pediatrics
12%
Low Density Lipoprotein Cholesterol
12%
Genetic Disorder
12%
Statin
12%
Low-Density Lipoprotein
12%
Ezetimibe
12%
Lipoprotein Apheresis
12%
Biochemistry, Genetics and Molecular Biology
Genetic Carrier
100%
Heterozygote
100%
Familial Hypercholesterolemia
100%
Cholesterol Level
25%
Metabolic Pathway
12%
Lipid
12%
Lipoprotein
12%
Low-Density Lipoprotein
12%
Genetic Disorder
12%
Low Density Lipoprotein Cholesterol Level
12%
Statin
12%
Apheresis
12%